MX9202616A - Nuevos hetariloxi-beta-carbolinos, su produccion y uso en agentes farmaceuticos. - Google Patents

Nuevos hetariloxi-beta-carbolinos, su produccion y uso en agentes farmaceuticos.

Info

Publication number
MX9202616A
MX9202616A MX9202616A MX9202616A MX9202616A MX 9202616 A MX9202616 A MX 9202616A MX 9202616 A MX9202616 A MX 9202616A MX 9202616 A MX9202616 A MX 9202616A MX 9202616 A MX9202616 A MX 9202616A
Authority
MX
Mexico
Prior art keywords
carbolines
beta
production
pharmaceutical agents
hetariloxi
Prior art date
Application number
MX9202616A
Other languages
English (en)
Inventor
Martin Kruger
Andreas Huth
Dieter Seidelmann
Herbert Schneider
Lechoslaw Turski
David Norman Stephens
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9202616A publication Critical patent/MX9202616A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Hetariloxi-beta-carbolinos de la fórmula (I), en los cuales, RA significa un radical hetarilo benzocondensado o de triazina con 1-2 átomos de nitrógeno opcionalmente substituídos con halógeno, alquilo con 1-6 átomos de carbono, alcoxi con 1-6 átomos de carbono, alquiltio con 1-6 átomos de carbono, trifluorometilo o SO2-R1 o un radical de hetarilo de 5 ó 6 miembros con 1-2 átomos de nitrógeno substituído con halógeno, alquilo con 1-6 átomos de carbono, alcoxi con 1-6 átomos de carbono, alquiltio con 1-6 átomos de carbono , trifluorometilo ó SO2-R1, son descritos, así como también su producción y su empleo en agentes farmacéuticos.
MX9202616A 1991-06-05 1992-06-02 Nuevos hetariloxi-beta-carbolinos, su produccion y uso en agentes farmaceuticos. MX9202616A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4118741A DE4118741A1 (de) 1991-06-05 1991-06-05 Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
MX9202616A true MX9202616A (es) 1993-09-01

Family

ID=6433410

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202616A MX9202616A (es) 1991-06-05 1992-06-02 Nuevos hetariloxi-beta-carbolinos, su produccion y uso en agentes farmaceuticos.

Country Status (21)

Country Link
US (2) US5348958A (es)
EP (1) EP0541757A1 (es)
JP (1) JPH06500341A (es)
KR (1) KR930701440A (es)
CN (1) CN1039906C (es)
AU (1) AU658631B2 (es)
CA (1) CA2087098A1 (es)
CZ (1) CZ281810B6 (es)
DE (1) DE4118741A1 (es)
FI (1) FI930293A0 (es)
HU (1) HUT63166A (es)
IE (1) IE921825A1 (es)
IL (1) IL102116A (es)
MX (1) MX9202616A (es)
NO (1) NO300771B1 (es)
NZ (1) NZ243014A (es)
PL (1) PL172481B1 (es)
PT (1) PT100565A (es)
RU (1) RU2105766C1 (es)
WO (1) WO1992021679A1 (es)
ZA (1) ZA924127B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4308788A1 (de) * 1993-03-18 1994-09-22 Bayer Ag Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4330175A1 (de) * 1993-08-31 1995-03-02 Schering Ag Alkoxy-substituierte beta-Carboline
GB0108337D0 (en) * 2001-04-03 2001-05-23 Novartis Ag Organic compounds
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US20220411273A1 (en) * 2019-11-27 2022-12-29 Wacker Chemie Ag Method for removing an impurity from a chlorosilane mixture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
IL87563A (en) * 1987-08-28 1993-08-18 Schering Ag Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln

Also Published As

Publication number Publication date
PL172481B1 (pl) 1997-09-30
CA2087098A1 (en) 1992-12-06
WO1992021679A1 (de) 1992-12-10
FI930293A (fi) 1993-01-25
FI930293A0 (fi) 1993-01-25
KR930701440A (ko) 1993-06-11
AU1807492A (en) 1992-12-10
PL297839A1 (en) 1993-11-02
ZA924127B (en) 1993-02-24
US5348958A (en) 1994-09-20
IL102116A (en) 1997-02-18
EP0541757A1 (de) 1993-05-19
AU658631B2 (en) 1995-04-27
CN1039906C (zh) 1998-09-23
US5698555A (en) 1997-12-16
HUT63166A (en) 1993-07-28
IL102116A0 (en) 1993-01-14
IE921825A1 (en) 1992-12-16
NO930390D0 (no) 1993-02-04
NZ243014A (en) 1995-04-27
NO300771B1 (no) 1997-07-21
RU2105766C1 (ru) 1998-02-27
JPH06500341A (ja) 1994-01-13
DE4118741A1 (de) 1992-12-10
CZ396892A3 (en) 1993-10-13
PT100565A (pt) 1993-08-31
CN1069270A (zh) 1993-02-24
HU9300595D0 (en) 1993-05-28
NO930390L (no) 1993-02-04
CZ281810B6 (cs) 1997-02-12

Similar Documents

Publication Publication Date Title
ES2134226T3 (es) Derivados de s-triazina como fotoestabilizadores.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
DE10299042I2 (de) Verwendung von Tetrahydrocarbazolderivaten als 5HT1-Rezeptor-agonisten.
AR023777A1 (es) Nuevos compuestos
CY1109153T1 (el) Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
ES2096560T3 (es) Compuestos de benzocicloheptapiridina sustituida con fluor, composiciones y metodos para uso como compuestos antihistaminicos.
FI940393A (fi) Kinatsoliinijohdannaiset asetyylikoliiniesteraasi-inhibiittoreina
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
IT1269176B (it) Eterobicicli ad attivita' fungicida
ES2092585T3 (es) Polioxazolidinas con grupos carbonato, procedimiento para su preparacion y su empleo.
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
MX9202616A (es) Nuevos hetariloxi-beta-carbolinos, su produccion y uso en agentes farmaceuticos.
DE69121334D1 (de) DC-89-Derivate als Antitumor-Wirkstoffe
ES2057679T3 (es) Piridinas substituidas.
WO1987004923A3 (fr) Amides aromatiques absorbant les u.v.
ES2052850T3 (es) Un procedimiento para preparar un compuesto de hidrazona.
ATE58636T1 (de) Gamma-thiobutyrolactonderivate gegen krampf.
IT1271443B (it) Derivati eterobiciclici ad attivita' fungicida
DE69320653T2 (de) Tetrahydrocarbazolderivate als 5-ht1-ähnliche agonisten
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
DE69013413D1 (de) Geregelte Gleichstromleistungsversorgung.
ES2105633T3 (es) Derivados de pirimidinona condensada a heterociclos nitrogenados con actividad antagonista de a ii.
ITMI932073A1 (it) Derivati di tioalchiltio carbacefalosporina e loro uso come antibiotici

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees